Form 8-K - Current report:
SEC Accession No. 0001193125-25-113364
Filing Date
2025-05-06
Accepted
2025-05-06 08:03:42
Documents
15
Period of Report
2025-05-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d70963d8k.htm   iXBRL 8-K 36293
2 EX-99.1 d70963dex991.htm EX-99.1 10158
  Complete submission text file 0001193125-25-113364.txt   215221

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sln-20250505.xsd EX-101.SCH 3534
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sln-20250505_def.xml EX-101.DEF 14077
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE sln-20250505_lab.xml EX-101.LAB 23244
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sln-20250505_pre.xml EX-101.PRE 14924
17 EXTRACTED XBRL INSTANCE DOCUMENT d70963d8k_htm.xml XML 5860
Mailing Address 72 HAMMERSMITH ROAD LONDON X0 W14 8TH
Business Address 72 HAMMERSMITH ROAD LONDON X0 W14 8TH 44-0-20-3457 6900
Silence Therapeutics plc (Filer) CIK: 0001479615 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0
Type: 8-K | Act: 34 | File No.: 001-39487 | Film No.: 25915313
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)